Emergent BioSolutions Inc. (NYSE: EBS) today announced a multi-year agreement with SAB Biotherapeutics, Inc. (Nasdaq: SABS, SAB BIO) to support the process development and manufacturing of SAB-142, ...

Emergent BioSolutions Inc. (NYSE: EBS) today announced a multi-year agreement with SAB Biotherapeutics, Inc. (NASDAQ: SABS) to support the process development and manufacturing of SAB-142, SAB BIO’s ...

HPLC Bio-Based Solvents MilliporeSigma recently launched a line-up of patent-pending bio-based solvents for HPLC. Made from ...

Inc. (NYSE: EBS) today announced a multi-year agreement with SAB Biotherapeutics, Inc. (Nasdaq: SABS, SAB BIO) to support the process ...

HPLC Bio-Based Solvents Merck recently launched a line-up of patent-pending bio-based solvents for HPLC. Made from renewable ...

Analytical performance should lead method decisions, but optimization can still reduce solvent, energy, and waste provided ...

Merck, a leading science and technology company, has launched the first bio-based solvent portfolio specifically for high-performance liquid chromatography (HPLC). Manufactured using renewable ...

Thematic coverage includes emerging contaminants and microplastics, exposomics, miniaturized sample preparation, sensor ...

As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their safety and efficacy. Method validation ensures the reliability of ...

Viral safety will be a major challenge for the CGT industry for the foreseeable future, according to new analysis.

Eurofins Scientific SE (the “Company”) (EUFI.PA) (Paris:ERF) announces its intention to launch a new buy-back programme of ...